Skip to main content
Premium Trial:

Request an Annual Quote

Caleb Brett to Buy PerkinElmer s Automotive Research Division

NEW YORK, Nov. 2 (GenomeWeb News) - PerkinElmer agreed on Oct. 26 to sell its automotive division as part of  its divesture of non-life science businesses, the company said in a filing with the Securities and Exchange Commission yesterday.


As GenomeWeb News reported last month, PerkinElmer will sell its aerospace, semiconductor, and fluid-testing businesses in order to shift its focus to the health sciences and photonic markets.


PerkinElmer agreed to sell to Caleb Brett USA all of its assets related to developing, marketing and providing fuel, lubricant, and other vehicle-based testing services for the gasoline engine and petrochemical industries, the SEC filing said.


Caleb Brett will pay $34.5 million in cash, subject to a post-closing adjustment based on PerkinElmer's working capital at closing.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.